Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityDividends payablesLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetMortgage LoansNon-Current DebtPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Advanced Flower Capital (AFCG) Cash & Equivalents (2022 - 2025)

Advanced Flower Capital (AFCG) has 4 years of Cash & Equivalents data on record, last reported at $38.6 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 62.74% year-over-year to $38.6 million; the TTM value through Dec 2025 reached $38.6 million, down 62.74%, while the annual FY2025 figure was $38.6 million, 62.74% down from the prior year.
  • Cash & Equivalents reached $38.6 million in Q4 2025 per AFCG's latest filing, down from $45.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $170.3 million in Q2 2024 and bottomed at $3.3 million in Q1 2025.
  • Average Cash & Equivalents over 4 years is $72.7 million, with a median of $68.4 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: soared 101.56% in 2023, then plummeted 98.0% in 2025.
  • A 4-year view of Cash & Equivalents shows it stood at $140.4 million in 2022, then crashed by 35.61% to $90.4 million in 2023, then grew by 14.64% to $103.6 million in 2024, then tumbled by 62.74% to $38.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $38.6 million in Q4 2025, $45.1 million in Q3 2025, and $3.4 million in Q2 2025.